Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells - PubMed (original) (raw)
Generation of in vitro autologous human cytotoxic T-cell response to E7 and HER-2/neu oncogene products using ex-vivo peptide loaded dendritic cells
H Navabi et al. Adv Exp Med Biol. 1997.
No abstract available
Similar articles
- Dendritic cell-based tumor vaccine for cervical cancer I: in vitro stimulation with recombinant protein-pulsed dendritic cells induces specific T cells to HPV16 E7 or HPV18 E7.
Nonn M, Schinz M, Zumbach K, Pawlita M, Schneider A, Dürst M, Kaufmann AM. Nonn M, et al. J Cancer Res Clin Oncol. 2003 Sep;129(9):511-20. doi: 10.1007/s00432-003-0462-6. Epub 2003 Aug 2. J Cancer Res Clin Oncol. 2003. PMID: 12905010 - Generation of tumor-specific cytotoxic T lymphocytes by stimulation with HPV type 16 E7 peptide-pulsed dendritic cells: an approach to immunotherapy of cervical cancer.
Schoell WM, Mirhashemi R, Liu B, Janicek MF, Podack ER, Penalver MA, Averette HE. Schoell WM, et al. Gynecol Oncol. 1999 Sep;74(3):448-55. doi: 10.1006/gyno.1999.5504. Gynecol Oncol. 1999. PMID: 10479508 - Exosomes in cancer immunotherapy: preclinical data.
Andre F, Andersen M, Wolfers J, Lozier A, Raposo G, Serra V, Ruegg C, Flament C, Angevin E, Amigorena S, Zitvogel L. Andre F, et al. Adv Exp Med Biol. 2001;495:349-54. doi: 10.1007/978-1-4615-0685-0_49. Adv Exp Med Biol. 2001. PMID: 11774591 Review. No abstract available. - Ins and outs of clinical trials with peptide-based vaccines.
Salit RB, Kast WM, Velders MP. Salit RB, et al. Front Biosci. 2002 May 1;7:e204-13. doi: 10.2741/salit. Front Biosci. 2002. PMID: 11991853 Review.
Cited by
- Efficacy of a Dual-Epitope Dendritic Cell Vaccine as Part of Combined Immunotherapy for HER2-Expressing Breast Tumors.
Vincent BG, File DM, McKinnon KP, Moore DT, Frelinger JA, Collins EJ, Ibrahim JG, Bixby L, Reisdorf S, Laurie SJ, Park YA, Anders CK, Collichio FA, Muss HB, Carey LA, van Deventer HW, Dees EC, Serody JS. Vincent BG, et al. J Immunol. 2023 Jul 15;211(2):219-228. doi: 10.4049/jimmunol.2300077. J Immunol. 2023. PMID: 37204246 Free PMC article. Clinical Trial. - Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F. Galea-Lauri J, et al. Cancer Immunol Immunother. 2004 Nov;53(11):963-77. doi: 10.1007/s00262-004-0542-8. Epub 2004 May 14. Cancer Immunol Immunother. 2004. PMID: 15146294 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous